http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1607396-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc19d8d6ba9ad5c1fa5770341472b56 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2000-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d64895f600d9cff9a9d96df63e262f12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b338844b16d90848a6a4659ce2d9ef04 |
| publicationDate | 2005-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1607396-A1 |
| titleOfInvention | Bicyclic inhibitors of glycogen synthase kinase 3 |
| abstract | Bicyclic based compounds of the formula (I) compositions andnmethods of inhibiting the activity of glycogen synthase kinasen(GSK3) in vitro and a treatment of GSK3 mediated disorders innvivo are provided. The methods, compounds and compositions ofnthe invention may be employed alone, or in combination withnother pharmacologically active agents in the treatment ofndisorders mediated by GSK3 activity, such as in the treatmentnof diabetes, Alzheimer's disease and other neurodegenerativendisorders, obesity, atherosclerotic cardiovascular disease,nessential hypertension, polycystic ovary syndrome, syndrome X,nischemia, traumatic brain injury, bipolar disorder,nimmunodeficiency or cancer. |
| priorityDate | 1999-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 986.